ArticleCancer research2024

Targeting Transcriptional Regulation with a CDK9 Inhibitor Suppresses Growth of Endocrine- and Palbociclib-Resistant ER+ Breast Cancers.

Arany Soosainathan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.